[go: up one dir, main page]

BRPI9908557B8 - processo para separação enanciomérica enzimática de 3(r)-hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahidro-piridina e 3-(s)- hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahidro-piridina e os ésteres de ácido carboxílico - Google Patents

processo para separação enanciomérica enzimática de 3(r)-hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahidro-piridina e 3-(s)- hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahidro-piridina e os ésteres de ácido carboxílico

Info

Publication number
BRPI9908557B8
BRPI9908557B8 BRPI9908557A BRPI9908557A BRPI9908557B8 BR PI9908557 B8 BRPI9908557 B8 BR PI9908557B8 BR PI9908557 A BRPI9908557 A BR PI9908557A BR PI9908557 A BRPI9908557 A BR PI9908557A BR PI9908557 B8 BRPI9908557 B8 BR PI9908557B8
Authority
BR
Brazil
Prior art keywords
trimethoxyphenyl
hydroxy
methyl
tetrahydro
pyridine
Prior art date
Application number
BRPI9908557A
Other languages
English (en)
Inventor
Holla Wolfgang
Original Assignee
Aventis Pharma Deutschland Gmbh
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh, Sanofi Aventis Deutschland filed Critical Aventis Pharma Deutschland Gmbh
Publication of BRPI9908557B1 publication Critical patent/BRPI9908557B1/pt
Publication of BRPI9908557B8 publication Critical patent/BRPI9908557B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/001Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by metabolizing one of the enantiomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/814Enzyme separation or purification
    • Y10S435/816Enzyme separation or purification by solubility

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)

Abstract

patente de invenção: <b>"processo para separação enanciomérica enzimática de 3(r)-hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahidro-piridina e 3-(s)- hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahidro-piridina e os ésteres de ácido carboxílico"<d>. é descrito um processo para preparação de compostos oticamente puros de 3(r)-hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahidro-piridina ou 3(s)-hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahidropiridina e, dos ésteres de ácido carboxílico, por conversão estereodiferenciada das misturas enancioméricas com auxílio de uma enzima.
BRPI9908557A 1998-03-06 1999-02-20 processo para separação enanciomérica enzimática de 3(r)-hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahidro-piridina e 3-(s)- hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahidro-piridina e os ésteres de ácido carboxílico BRPI9908557B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19809649A DE19809649A1 (de) 1998-03-06 1998-03-06 Verfahren zur enzymatischen Enantiomeren-Trennung von 3(R)- und 3(S)-Hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-1,2,3,6-tetrahydro-pyridin bzw. der Carbonsäureester
PCT/EP1999/001113 WO1999045133A1 (de) 1998-03-06 1999-02-20 Verfarhen zur enzymatischen enantiomeren-trennung von 3(r)- und 3(s)-hydroxy-1- methyl-4-(2,4, 6-trimethoxyphenyl)-1, 2,3,6- tetrahydro-pyridin bzw. der carbonsäureester

Publications (2)

Publication Number Publication Date
BRPI9908557B1 BRPI9908557B1 (pt) 2018-09-18
BRPI9908557B8 true BRPI9908557B8 (pt) 2021-05-25

Family

ID=7859957

Family Applications (2)

Application Number Title Priority Date Filing Date
BR9908557-7A BR9908557A (pt) 1998-03-06 1999-02-20 Processo para separação enanciomérica enzimática de 3(r)-hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetr ahidro-piridina e 3-(s)- hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahid ro-piridina e os ésteres de ácido carboxìlico
BRPI9908557A BRPI9908557B8 (pt) 1998-03-06 1999-02-20 processo para separação enanciomérica enzimática de 3(r)-hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahidro-piridina e 3-(s)- hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahidro-piridina e os ésteres de ácido carboxílico

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR9908557-7A BR9908557A (pt) 1998-03-06 1999-02-20 Processo para separação enanciomérica enzimática de 3(r)-hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetr ahidro-piridina e 3-(s)- hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahid ro-piridina e os ésteres de ácido carboxìlico

Country Status (22)

Country Link
US (1) US6406912B1 (pt)
EP (1) EP1071807B1 (pt)
JP (1) JP4344089B2 (pt)
KR (1) KR100779864B1 (pt)
CN (1) CN1230554C (pt)
AR (1) AR018574A1 (pt)
AT (1) ATE474061T1 (pt)
AU (1) AU758106B2 (pt)
BR (2) BR9908557A (pt)
CA (1) CA2322842C (pt)
CY (1) CY1110919T1 (pt)
CZ (1) CZ301944B6 (pt)
DE (2) DE19809649A1 (pt)
DK (1) DK1071807T3 (pt)
ES (1) ES2348394T3 (pt)
HU (1) HU227994B1 (pt)
ID (1) ID27000A (pt)
PL (1) PL195006B1 (pt)
PT (1) PT1071807E (pt)
RU (1) RU2241040C2 (pt)
TR (1) TR200002576T2 (pt)
WO (1) WO1999045133A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1194507B1 (en) 1999-05-13 2003-02-26 Shell Internationale Researchmaatschappij B.V. Hydrocarbon conversion process
BR0209657B1 (pt) * 2001-05-15 2014-10-21 Speedel Pharma Ag Processo para a preparação de ésteres de ácidos carboxílicos substituídos por hidrólise enzimática
CN104232700A (zh) * 2014-10-01 2014-12-24 青岛科技大学 一种生物法生产(2r,3s)羟基丙酸甲酯的方法
CN104278061A (zh) * 2014-10-01 2015-01-14 青岛科技大学 一种生产氟苯基甲基丙酸甲酯的产朊酵母还原法
CA2982928A1 (en) 2015-04-20 2016-10-27 Tolero Pharmaceuticals, Inc. Predicting response to alvocidib by mitochondrial profiling
DK3298021T3 (da) 2015-05-18 2019-08-05 Tolero Pharmaceuticals Inc Alvocidib-prodrugs, der har øget biotilgængelighed
AU2016301315C1 (en) 2015-08-03 2022-07-07 Sumitomo Pharma Oncology, Inc. Combination therapies for treatment of cancer
US11279694B2 (en) 2016-11-18 2022-03-22 Sumitomo Dainippon Pharma Oncology, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
MX2019007332A (es) 2016-12-19 2019-11-18 Tolero Pharmaceuticals Inc Péptidos indicadores y métodos para caracterizar sensibilidad.
US11497756B2 (en) 2017-09-12 2022-11-15 Sumitomo Pharma Oncology, Inc. Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib
MX2021006544A (es) 2018-12-04 2021-07-07 Sumitomo Pharma Oncology Inc Inhibidores de cinasa dependiente de ciclina 9 (cdk9) y polimorfos de los mismos para uso como agentes para el tratamiento de cancer.
WO2020191326A1 (en) 2019-03-20 2020-09-24 Sumitomo Dainippon Pharma Oncology, Inc. Treatment of acute myeloid leukemia (aml) with venetoclax failure
CN110577974B (zh) * 2019-09-10 2021-07-20 杭州澳赛诺生物科技有限公司 手性3-羟基-1,2,3,6-四氢吡啶的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2691986B2 (ja) * 1987-08-28 1997-12-17 チッソ株式会社 ピリジン骨格を有する光学活性化合物の製造法
DE3743824C2 (de) * 1987-12-23 1997-03-06 Hoechst Ag Verfahren zur enzymatischen Racematspaltung von racemischen Alkoholen mit/in Vinylestern durch Umesterung
JPH0641075A (ja) * 1990-09-01 1994-02-15 Kazuo Achinami 新規な1,4−ジヒドロピリジン化合物及びその製造方法
JPH05192145A (ja) * 1991-04-02 1993-08-03 Hoechst Ag 固定化生体触媒、その製造およびカラムリアクター中でのエステル合成におけるその使用
JPH0690790A (ja) 1992-09-08 1994-04-05 Mercian Corp 光学活性1,4−ジヒドロピリジン−3,5−ジカルボン酸・モノエステル誘導体の製造方法
DE19802449A1 (de) * 1998-01-23 1999-07-29 Hoechst Marion Roussel De Gmbh Verfahren zur Herstellung von (-)cis-3-Hydroxy-1-methyl-4-(2,4,6-trimethoxypyhenyl)-piperidin

Also Published As

Publication number Publication date
CZ301944B6 (cs) 2010-08-11
EP1071807A1 (de) 2001-01-31
DK1071807T3 (da) 2010-11-08
BRPI9908557B1 (pt) 2018-09-18
WO1999045133A1 (de) 1999-09-10
ATE474061T1 (de) 2010-07-15
US6406912B1 (en) 2002-06-18
AU758106B2 (en) 2003-03-13
CN1230554C (zh) 2005-12-07
TR200002576T2 (tr) 2000-11-21
HK1035001A1 (en) 2001-11-09
CY1110919T1 (el) 2015-06-10
PL195006B1 (pl) 2007-07-31
HU227994B1 (en) 2012-08-28
AU2927599A (en) 1999-09-20
JP2002505112A (ja) 2002-02-19
AR018574A1 (es) 2001-11-28
HUP0101795A2 (hu) 2001-09-28
ES2348394T3 (es) 2010-12-03
PL342877A1 (en) 2001-07-16
CZ20003223A3 (cs) 2000-11-15
CN1292034A (zh) 2001-04-18
BR9908557A (pt) 2000-11-21
HUP0101795A3 (en) 2004-03-01
PT1071807E (pt) 2010-09-29
CA2322842C (en) 2011-04-05
ID27000A (id) 2001-02-22
DE19809649A1 (de) 1999-09-09
KR100779864B1 (ko) 2007-11-27
EP1071807B1 (de) 2010-07-14
CA2322842A1 (en) 1999-09-10
KR20010041643A (ko) 2001-05-25
JP4344089B2 (ja) 2009-10-14
DE59915183D1 (de) 2010-08-26
RU2241040C2 (ru) 2004-11-27

Similar Documents

Publication Publication Date Title
BRPI9908557B8 (pt) processo para separação enanciomérica enzimática de 3(r)-hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahidro-piridina e 3-(s)- hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-1,2,3,6-tetrahidro-piridina e os ésteres de ácido carboxílico
EP0727496A3 (en) DNA polymerases
PT923554E (pt) N-benzilpiperidina e derivados tetrahidropiridina
BR9607640A (pt) Processo para remover impurezas de argilas de caulim
FI894022A0 (fi) Menetelmä (2R,3S)-3-(4-metoksifenyyli)glysidiinihapon alemman alkyyliesterin valmistamiseksi
AU2856589A (en) Intermediates for the preparation of 11-substituted 5H, 11H-pyrrole (2,1-c) (1,4) benzoxazepines, and a method for their preparation
BR9809687A (pt) Processo novo
BR0001342A (pt) Processo para a produção de l-aminoácidos por meio de fermentação usando bactérias corineformes
EP0855446A3 (en) Process for producing optically active azetidine-2-carboxylic acid derivative
BR9608237A (pt) Processos para preparar 1-(piridil)-2-cicloexiletilamina racêmica e anantiomérica.
DE3851865D1 (de) Verfahren zur Umwandlung des niedrigschmelzenden Polymorphs von Buspirone hydrochlorid in das höherschmelzende.
BR0012481A (pt) Processo para desacilação de lipodepsipeptìdeos
BR9803289A (pt) Processo para a preparação de ácido 4-(4-(4-(hridroxidifenil)-1-piperidinil)-1hidroxibutil)- alfa,alfa-dimetifenilacético e derivados fosforilados.
EP0974670A3 (en) Process for producing optically active N-substituted azetidine-2-carboxylic acid compound
BR9811579A (pt) Processo para preparação de ácidos 3-ciano-2,4-dialógeno-5-fluorobenzóicos
BR9812351A (pt) Novo processo estereoseletivo para a preparação de análogas gabapentinas
DE69534491D1 (de) Cephalosporin-c-amidohydrolase herstellung und verwendung
AU585703B2 (en) Process for the enzymatic resolution of racemic 2-amino- 1-alkanols
FR2708603B1 (fr) Procédé de préparation d&#39;hydroperoxyde de cumène.
DE69432000D1 (de) Verwendung von Tetrahydropyridinderivaten zur Herstellung von Kardioprotektiven Medikamenten
AU5390094A (en) Chiral lactic acid derivatives
DE3563963D1 (de) Azetidine derivatives
SE9901712D0 (sv) New process
WO2001030991A3 (en) Human narcolepsy gene
EP0795609A3 (en) Process for preparing optically active trans-3-phenylglycidamide compounds